These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

377 related items for PubMed ID: 10460158

  • 1. Effect of DNA polymerases and high mobility group protein 1 on the carrier ligand specificity for translesion synthesis past platinum-DNA adducts.
    Vaisman A, Lim SE, Patrick SM, Copeland WC, Hinkle DC, Turchi JJ, Chaney SG.
    Biochemistry; 1999 Aug 24; 38(34):11026-39. PubMed ID: 10460158
    [Abstract] [Full Text] [Related]

  • 2. Specificity of platinum-DNA adduct repair.
    Chaney SG, Vaisman A.
    J Inorg Biochem; 1999 Oct 24; 77(1-2):71-81. PubMed ID: 10626357
    [Abstract] [Full Text] [Related]

  • 3. Efficiency of extension of mismatched primer termini across from cisplatin and oxaliplatin adducts by human DNA polymerases beta and eta in vitro.
    Bassett E, Vaisman A, Havener JM, Masutani C, Hanaoka F, Chaney SG.
    Biochemistry; 2003 Dec 09; 42(48):14197-206. PubMed ID: 14640687
    [Abstract] [Full Text] [Related]

  • 4. Recognition and processing of cisplatin- and oxaliplatin-DNA adducts.
    Chaney SG, Campbell SL, Bassett E, Wu Y.
    Crit Rev Oncol Hematol; 2005 Jan 09; 53(1):3-11. PubMed ID: 15607931
    [Abstract] [Full Text] [Related]

  • 5. The role of DNA polymerase eta in translesion synthesis past platinum-DNA adducts in human fibroblasts.
    Bassett E, King NM, Bryant MF, Hector S, Pendyala L, Chaney SG, Cordeiro-Stone M.
    Cancer Res; 2004 Sep 15; 64(18):6469-75. PubMed ID: 15374956
    [Abstract] [Full Text] [Related]

  • 6. Efficient translesion replication past oxaliplatin and cisplatin GpG adducts by human DNA polymerase eta.
    Vaisman A, Masutani C, Hanaoka F, Chaney SG.
    Biochemistry; 2000 Apr 25; 39(16):4575-80. PubMed ID: 10769112
    [Abstract] [Full Text] [Related]

  • 7. Binding of Ixr1, a yeast HMG-domain protein, to cisplatin-DNA adducts in vitro and in vivo.
    McA'Nulty MM, Whitehead JP, Lippard SJ.
    Biochemistry; 1996 May 14; 35(19):6089-99. PubMed ID: 8634251
    [Abstract] [Full Text] [Related]

  • 8. Photoreactivity of platinum(II) in cisplatin-modified DNA affords specific cross-links to HMG domain proteins.
    Kane SA, Lippard SJ.
    Biochemistry; 1996 Feb 20; 35(7):2180-8. PubMed ID: 8652559
    [Abstract] [Full Text] [Related]

  • 9. Frameshifts and deletions during in vitro translesion synthesis past Pt-DNA adducts by DNA polymerases beta and eta.
    Bassett E, Vaisman A, Tropea KA, McCall CM, Masutani C, Hanaoka F, Chaney SG.
    DNA Repair (Amst); 2002 Dec 05; 1(12):1003-16. PubMed ID: 12531010
    [Abstract] [Full Text] [Related]

  • 10. Basis for recognition of cisplatin-modified DNA by high-mobility-group proteins.
    Ohndorf UM, Rould MA, He Q, Pabo CO, Lippard SJ.
    Nature; 1999 Jun 17; 399(6737):708-12. PubMed ID: 10385126
    [Abstract] [Full Text] [Related]

  • 11. Polymerization by DNA polymerase eta is blocked by cis-diamminedichloroplatinum(II) 1,3-d(GpTpG) cross-link: implications for cytotoxic effects in nucleotide excision repair-negative tumor cells.
    Chijiwa S, Masutani C, Hanaoka F, Iwai S, Kuraoka I.
    Carcinogenesis; 2010 Mar 17; 31(3):388-93. PubMed ID: 20015866
    [Abstract] [Full Text] [Related]

  • 12. HMG1 protein inhibits the translesion synthesis of the major DNA cisplatin adduct by cell extracts.
    Hoffmann JS, Locker D, Villani G, Leng M.
    J Mol Biol; 1997 Jul 25; 270(4):539-43. PubMed ID: 9245584
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Platinum-DNA interactions and subsequent cellular processes controlling sensitivity to anticancer platinum complexes.
    Ahmad S.
    Chem Biodivers; 2010 Mar 25; 7(3):543-66. PubMed ID: 20232326
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The N2-ethylguanine and the O6-ethyl- and O6-methylguanine lesions in DNA: contrasting responses from the "bypass" DNA polymerase eta and the replicative DNA polymerase alpha.
    Perrino FW, Blans P, Harvey S, Gelhaus SL, McGrath C, Akman SA, Jenkins GS, LaCourse WR, Fishbein JC.
    Chem Res Toxicol; 2003 Dec 25; 16(12):1616-23. PubMed ID: 14680376
    [Abstract] [Full Text] [Related]

  • 17. The efficiency and fidelity of translesion synthesis past cisplatin and oxaliplatin GpG adducts by human DNA polymerase beta.
    Vaisman A, Chaney SG.
    J Biol Chem; 2000 Apr 28; 275(17):13017-25. PubMed ID: 10777605
    [Abstract] [Full Text] [Related]

  • 18. Translesion synthesis past platinum DNA adducts by human DNA polymerase mu.
    Havener JM, Nick McElhinny SA, Bassett E, Gauger M, Ramsden DA, Chaney SG.
    Biochemistry; 2003 Feb 18; 42(6):1777-88. PubMed ID: 12578393
    [Abstract] [Full Text] [Related]

  • 19. Protein interactions with platinum-DNA adducts: from structure to function.
    Chaney SG, Campbell SL, Temple B, Bassett E, Wu Y, Faldu M.
    J Inorg Biochem; 2004 Oct 18; 98(10):1551-9. PubMed ID: 15458816
    [Abstract] [Full Text] [Related]

  • 20. Cisplatin-DNA adducts inhibit ribosomal RNA synthesis by hijacking the transcription factor human upstream binding factor.
    Zhai X, Beckmann H, Jantzen HM, Essigmann JM.
    Biochemistry; 1998 Nov 17; 37(46):16307-15. PubMed ID: 9819223
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.